Real World Experience of Tisagenlecleucel Chimeric Antigen Receptor (CAR) T-Cells Targeting CD19 in Patients with Acute Lymphoblastic Leukemia (ALL) and Diffuse Large B-Cell Lymphoma (DLBCL) Using the Center for International Blood and Marrow Transplant Research (CIBMTR) Cellular Therapy (CT) Registry
Authors:
- Marcelo PasquiniMPMarcelo Pasquini
- Zhen-Huan HuZHZhen-Huan Hu
- Yiyun ZhangYZYiyun Zhang
- Stephan GruppSGStephan Grupp
- Peiman HemattiPHPeiman Hematti
- Samantha JaglowskiSJSamantha Jaglowski
- Amy KeatingAKAmy Keating
- Sarah NikiforowSNSarah Nikiforow
- Christine PhilipsCPChristine Philips
- Michael PulsipherMPMichael Pulsipher
- Sweta ShahSSSweta Shah
- Patricia SteinertPSPatricia Steinert
- 1 September 2019
- journal article
- abstracts
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 19, S267